The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Antioxidants and Redox Signaling

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1089/ars.2016.6759PMID 27626216
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Editorial: Oxidative Stress and Alzheimer Disease: Where Do We Stand?

  2016cited by this paper
• Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia

  2016cited by this paper
• Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation

  2016cited by this paper
• Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.

  2016influential reference
• It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease

  2016cited by this paper
• Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.

  2016cited by this paper
• Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage.

  2015cited by this paper
• mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy.

  2015influential reference
• A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension

  2015cited by this paper
• Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's Syndrome

  2015cited by this paper
• Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling

  2015cited by this paper
• Phosphorylation of the translation initiation factor eIF2α at serine 51 determines the cell fate decisions of Akt in response to oxidative stress

  2015cited by this paper
• World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends

  2015cited by this paper
• Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD

  2015cited by this paper
• The unfolded protein response in neurodegenerative diseases: a neuropathological perspective

  2015influential reference
• Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients.

  2015cited by this paper
• How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.

  2015cited by this paper
• Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?

  2015cited by this paper
• Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants

  2015cited by this paper
• Glyceraldehyde-3-phosphate Dehydrogenase Aggregates Accelerate Amyloid-β Amyloidogenesis in Alzheimer Disease*

  2015cited by this paper
• Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β‐amyloid toxicity, and astrocyte function

  2015cited by this paper
• Hippocampal insulin resistance and cognitive dysfunction

  2015cited by this paper
• Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo.

  2015cited by this paper
• Redox regulation of autophagy in healthy brain and neurodegeneration.

  2015cited by this paper
• Impaired insulin action in the human brain: causes and metabolic consequences

  2015cited by this paper
• Aberrant insulin signaling in Alzheimer's disease: current knowledge

  2015cited by this paper
• Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.

  2014cited by this paper
• Insulin in the Brain: Its Pathophysiological Implications for States Related with Central Insulin Resistance, Type 2 Diabetes and Alzheimer’s Disease

  2014cited by this paper
• Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.

  2014influential reference
• mTOR signaling and its roles in normal and abnormal brain development

  2014cited by this paper
• Quality control: ER-associated degradation: protein quality control and beyond.

  2014cited by this paper
• mTOR Hyperactivation in down syndrome hippocampus appears early during development.

  2014cited by this paper
• Targeting the unfolded protein response in neurodegeneration: A new approach to therapy.

  2014cited by this paper
• Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease

  2014cited by this paper
• Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.

  2014cited by this paper
• Oxidative Stress and Proteostasis Network: Culprit and Casualty of Alzheimer’s-Like Neurodegeneration

  2014influential reference
• Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.

  2014influential reference
• Autophagy and apoptosis dysfunction in neurodegenerative disorders.

  2014cited by this paper
• The Akt-mTOR pathway in Down's syndrome: the potential use of rapamycin/rapalogs for treating cognitive deficits.

  2014cited by this paper
• The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration.

  2014cited by this paper
• Effects of Oxidative Stress on the Solubility of HRD1, a Ubiquitin Ligase Implicated in Alzheimer’s Disease

  2014cited by this paper
• Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

  2014influential reference
• Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: Insights from proteomics

  2014cited by this paper
• Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease☆

  2014cited by this paper
• Mass spectrometry and redox proteomics: applications in disease.

  2014influential reference
• Brain metabolic dysfunction at the core of Alzheimer's disease.

  2014cited by this paper
• Autophagy Modulation for Alzheimer’s Disease Therapy

  2013cited by this paper
• Endoplasmic reticulum dysfunction in neurological disease.

  2013cited by this paper
• Differential Activation of mTOR Complex 1 Signaling in Human Brain with Mild to Severe Alzheimer's Disease

  2013cited by this paper
• A Focused Review of the Role of Ketone Bodies in Health and Disease

  2013cited by this paper
• Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.

  2013cited by this paper
• PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.

  2013influential reference
• The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease

  2013cited by this paper
• Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease.

  2013influential reference
• Amyloid β-Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression

  2013cited by this paper
• Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.

  2013cited by this paper
• Sugar for the brain: the role of glucose in physiological and pathological brain function.

  2013influential reference
• Autophagic/lysosomal dysfunction in Alzheimer’s disease

  2013influential reference
• Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

  2013influential reference
• mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies

  2013cited by this paper
• The oxidative stress hypothesis in Alzheimer's disease.

  2013cited by this paper
• Lack of Genetic Association of the UCHL1 Gene with Alzheimer’s Disease and Parkinson’s Disease with Dementia

  2012cited by this paper
• Amyloid β-induced ER stress is enhanced under mitochondrial dysfunction conditions.

  2012cited by this paper
• Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.

  2012cited by this paper
• Analysis of a membrane‐enriched proteome from postmortem human brain tissue in Alzheimer's disease

  2012cited by this paper
• Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications

  2012influential reference
• An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

  2012cited by this paper
• PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• The role of mTOR signaling in Alzheimer disease.

  2012influential reference
• Insulin in Central Nervous System: More than Just a Peripheral Hormone

  2012cited by this paper
• Aβ1‐42‐mediated down‐regulation of Uch‐L1 is dependent on NF‐κB activation and impaired BACE1 lysosomal degradation

  2012cited by this paper
• The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies

  2012influential reference
• The impact of the unfolded protein response on human disease

  2012cited by this paper
• P1‐273: Changes in sleep/wake parameters in male PD‐APP transgenic mice

  2012cited by this paper
• Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.

  2012cited by this paper
• Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

  2012cited by this paper
• Mammalian target of rapamycin: A valid therapeutic target through the autophagy pathway for alzheimer's disease?

  2012cited by this paper
• Ubiquilin-1 regulates amyloid precursor protein maturation and degradation by stimulating K63-linked polyubiquitination of lysine 688

  2012influential reference
• Endoplasmic reticulum: the unfolded protein response is tangled in neurodegeneration.

  2012cited by this paper
• Autophagy and misfolded proteins in neurodegeneration

  2012influential reference
• The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals

  2011cited by this paper
• mTORC1 signaling in energy balance and metabolic disease

  2011cited by this paper
• Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation.

  2011influential reference
• Alzheimer's disease.

  2011cited by this paper
• Redox Proteomics Analysis of Brains from Subjects with Amnestic Mild Cognitive Impairment Compared to Brains from Subjects with Preclinical Alzheimer's Disease: Insights into Memory Loss in MCI

  2011cited by this paper
• Reactive oxygen species downregulate glucose transport system in retinal endothelial cells.

  2011cited by this paper
• Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases

  2011cited by this paper
• Insulin Resistance and Alzheimer’s Disease

  2011influential reference
• A review of the mammalian unfolded protein response

  2011cited by this paper
• Proteomic analysis of brain proteins in APP/PS‐1 human double mutant knock‐in mice with increasing amyloid β‐peptide deposition: Insights into the effects of in vivo treatment with N‐acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease

  2011cited by this paper
• Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial

  2011cited by this paper
• Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits.

  2011cited by this paper
• The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

  2011influential reference
• Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia

  2011influential reference
• Protein folding stress in neurodegenerative diseases: a glimpse into the ER.

  2011cited by this paper
• A Face in the Crowd: Recognizing Peptides Through Database Search*

  2011cited by this paper
• mTOR signaling in protein homeostasis

  2011cited by this paper
• Naturally Secreted Amyloid-β Increases Mammalian Target of Rapamycin (mTOR) Activity via a PRAS40-mediated Mechanism*

  2011cited by this paper
• Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated from Lymphocytes from Patients with Alzheimer's Disease: Insights into the Role of Oxidative Stress in Alzheimer's Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder

  2011cited by this paper

• New perspective on neurodegenerative diseases: Focusing on the interaction between autophagy and oxidative stress and targeted strategies.

  2026cites this paper
• P16-positive senescent cells promote DKD by the dysregulation of glycolysis and mitochondrial metabolism

  2025cites this paper
• Chronic Alcohol Use and Accelerated Brain Aging: Shared Mechanisms with Alzheimer’s Disease Pathophysiology

  2025cites this paper
• Exploring the Endoplasmic Reticulum's Role in Alzheimer's Disease and Its Potential as a Therapeutic Target

  2025cites this paper
• Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroinflammation mice model

  2025cites this paper
• Current insights and prospects for the pathogenesis and treatment of clinical manifestations associated with Down syndrome through neurotransmitter, inflammatory, and oxidative stress pathways

  2025cites this paper
• Secondary metabolites in plant-microbe interactions.

  2025cites this paper
• Insulin resistance: fueling oxidative stress and neurodegeneration

  2025cites this paper
• Metabolic breakdown: Linking insulin resistance and mitochondrial dysfunction to neurodegeneration in Alzheimer's disease.

  2025cites this paper
• Review on anti-alzheimer drug development: approaches, challenges and perspectives

  2024cites this paper
• Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

  2024cites this paper
• Redox imbalance and metabolic defects in the context of Alzheimer disease

  2024cites this paper
• The Usnic Acid Analogue 4-FPBUA Enhances the Blood-Brain Barrier Function and Induces Autophagy in Alzheimer's Disease Mouse Models.

  2024cites this paper
• Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer’s Disease

  2024cites this paper
• PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease

  2023cites this paper
• Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

  2023cites this paper
• The Neurobiology and Therapeutic Potential of Multi-Targeting β-secretase, Glycogen Synthase Kinase 3β and Acetylcholinesterase in Alzheimer's Disease.

  2023cites this paper
• The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer’s Disease Reveals New Insights for AD Study

  2023cites this paper
• mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis.

  2022cites this paper
• Oxidative stress and mTOR in Down syndrome brain: Link to Alzheimer's dysmetabolism, neuropathology, and possible therapies

  2022cites this paper
• Comorbidity of Osteoporosis and Alzheimer's Disease: Is `AKT `-ing on Cellular Glucose Uptake the Missing Link?

  2022cites this paper
• The interplay between oxidative stress and autophagy: focus on the development of neurological diseases

  2022cites this paper
• Overproduction of hydrogen sulfide, generated by cystathionine β-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of down syndrome

  2022cites this paper
• The significance of glycolysis index and its correlations with immune infiltrates in Alzheimer’s disease

  2022cites this paper
• Current Insights on Neurodegeneration by the Italian Proteomics Community

  2022cites this paper
• The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders.

  2022cites this paper
• Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells.

  2022cites this paper
• MCT2 overexpression promotes recovery of cognitive function by increasing mitochondrial biogenesis in a rat model of stroke

  2021cites this paper
• mTOR in Alzheimer Disease and Its Earlier Stages: Links to Oxidative Damage in the Progression of this Dementing Disorder.

  2021cites this paper
• mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease

  2021cites this paper
• The mTOR/NF-κB Pathway Mediates Neuroinflammation and Synaptic Plasticity in Diabetic Encephalopathy

  2021cites this paper
• High-Fat Diet Leads to Reduced Protein O-GlcNAcylation and Mitochondrial Defects Promoting the Development of Alzheimer’s Disease Signatures

  2021cites this paper
• Implication of Dietary Iron-Chelating Bioactive Compounds in Molecular Mechanisms of Oxidative Stress-Induced Cell Ageing

  2021cites this paper
• Brain insulin, insulin‐like growth factor 1 and glucagon‐like peptide 1 signalling in Alzheimer’s disease

  2021cites this paper
• Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules

  2021cites this paper
• Huanglian Jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer’s disease progression based on the “brain-gut” axis through multiple integrated omics

  2021cites this paper
• Alzheimer's Disease and Protein Kinases.

  2021cites this paper
• CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?

  2021cites this paper
• Brain insulin resistance: an early risk factor for Alzheimer's disease development in Down syndrome

  2021cites this paper
• Olive oil–contained phenolic compounds protect cells against H2O2-induced damage and modulate redox signaling by chelating intracellular labile iron

  2021cites this paper
• Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

  2021cites this paper
• Physical Activity vs. Redox Balance in the Brain: Brain Health, Aging and Diseases

  2021cites this paper
• Understanding Cellular Redox Homeostasis: A Challenge for Precision Medicine

  2021cites this paper
• Salivary gland dysfunction and salivary redox imbalance in patients with Alzheimer’s disease

  2021cites this paper
• Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

  2021cites this paper
• Ubiquitin carboxyl-terminal hydrolase L-1 in brain: Focus on its oxidative/nitrosative modification and role in brains of subjects with Alzheimer disease and mild cognitive impairment.

  2021cites this paper
• Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery

  2021cites this paper
• Oxidative Stress and Antioxidant Strategies in Human Diseases

  2021cites this paper
• The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease.

  2021cites this paper
• Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer’s Disease

  2020cites this paper
• Diseases of the nervous system

  2020cites this paper
• Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.

  2020cites this paper
• Diabetes–Alzheimer's Disease Link: Targeting Mitochondrial Dysfunction and Redox Imbalance

  2020cites this paper
• BRAIN LIPID PEROXIDATION AND ALZHEIMER DISEASE: SYNERGY BETWEEN THE BUTTERFIELD AND MATTSON LABORATORIES.

  2020cites this paper
• Insulin resistance and obesity

  2020cites this paper
• Inhibition of mTORC1 improves STZ-induced AD-like impairments in mice.

  2020cites this paper
• Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions

  2020cites this paper
• Comprehensive Isotopic Targeted Mass Spectrometry (CIT-MS): Reliable Metabolic Flux Analysis with Broad Coverage.

  2020cites this paper
• BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain—Implications for Neurodegeneration

  2020cites this paper
• Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention.

  2020cites this paper
• When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration

  2020cites this paper
• Redox Post-translational Modifications of Protein Thiols in Brain Aging and Neurodegenerative Conditions—Focus on S-Nitrosation

  2020cites this paper
• Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease

  2020cites this paper
• Signalling Pathways Implicated in Alzheimer′s Disease Neurodegeneration in Individuals with and without Down Syndrome

  2020cites this paper
• Jacobian Mapping Reveals Converging Substrates of Disruption and Repair in Response to Ethanol Exposure and Abstinence in Two Strains of Rats.

  2020cites this paper
• A transition to degeneration triggered by oxidative stress in degenerative disorders

  2020cites this paper
• Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children

  2020cites this paper
• The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome

  2020cites this paper
• Role of Insulin Signaling in the Pathophysiology of Alzheimer’s Disease

  2020cites this paper
• The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome

  2020cites this paper
• Shining a light on defective autophagy by proteomics approaches: implications for neurodegenerative illnesses

  2019cites this paper
• Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach

  2019cites this paper
• Granisetron Alleviates Alzheimer’s Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway

  2019cites this paper
• Glutaredoxin1 Diminishes Amyloid Beta-Mediated Oxidation of F-Actin and Reverses Cognitive Deficits in an Alzheimer's Disease Mouse Model

  2019cites this paper
• Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer’s disease

  2019cites this paper
• Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes.

  2019cites this paper
• Tortuous Paths of Insulin Signaling and Mitochondria in Alzheimer's Disease.

  2019cites this paper
• Protein carbonylation is a mediator in larvicidal mechanisms of Tabernaemontana cymosa ethanolic extract

  2019cites this paper
• Phosphoproteomics of Alzheimer disease brain: Insights into altered brain protein regulation of critical neuronal functions and their contributions to subsequent cognitive loss.

  2019cites this paper
• Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome

  2019cites this paper
• Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease

  2019cites this paper
• Mitochondrial transplantation as a potential and novel master key for treatment of various incurable diseases

  2019cites this paper
• Rapamycin and Alzheimer’s disease: Time for a clinical trial?

  2019cites this paper
• History and progress of hypotheses and clinical trials for Alzheimer’s disease

  2019cites this paper
• The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia

  2018influential citation
• Perspectives on Oxidative Stress in Alzheimer’s Disease and Predictions of Future Research Emphases

  2018cites this paper
• Jacobian Maps Reveal Under-reported Brain Regions Sensitive to Extreme Binge Ethanol Intoxication in the Rat

  2018cites this paper
• Lithocarpus polystachyus Rehd. leaves aqueous extract protects against hydrogen peroxide‑induced SH-SY5Y cells injury through activation of Sirt3 signaling pathway.

  2018cites this paper
• Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.

  2018cites this paper
• mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease‐like dementia

  2018cites this paper
• Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

  2018cites this paper
• Mini-Review: Oxidative stress, redox stress or redox success?

  2018cites this paper
• Reactions of Alkyl Radicals in Aqueous Solutions*

  2018cites this paper
• Healthy brain aging: Interplay between reactive species, inflammation and energy supply.

  2018cites this paper
• Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

  2018cites this paper
• Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds

  2018cites this paper
• Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease

  2018cites this paper
• Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.

  2018cites this paper
• Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: Implications for Alzheimer disease.

  2018cites this paper
• Ergothioneine – a diet‐derived antioxidant with therapeutic potential

  2018cites this paper